Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020.
de Gier B, de Oliveira Bressane Lima P, van Gaalen RD, de Boer PT, Alblas J, Ruijten M, van Gageldonk-Lafeber AB, Waegemaekers T, Schreijer A, van den Hof S, Hahné SJ. de Gier B, et al. Among authors: de boer pt. Euro Surveill. 2020 Dec;25(50):2001884. doi: 10.2807/1560-7917.ES.2020.25.50.2001884. Euro Surveill. 2020. PMID: 33334396 Free PMC article.
The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
McDonald SA, Lagerweij GR, de Boer P, de Melker HE, Pijnacker R, Mughini Gras L, Kretzschmar ME, den Hartog G, van Gageldonk-Lafeber AB; RIVM COVID-19 surveillance, epidemiology team; van den F S, Wallinga J. McDonald SA, et al. Eur J Epidemiol. 2022 Oct;37(10):1035-1047. doi: 10.1007/s10654-022-00895-0. Epub 2022 Aug 11. Eur J Epidemiol. 2022. PMID: 35951278 Free PMC article.
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.
de Boer PT, van de Kassteele J, Vos ERA, van Asten L, Dongelmans DA, van Gageldonk-Lafeber AB, den Hartog G, Hofhuis A, van der Klis F, de Lange DW, Stoeldraijer L; RIVM COVID‐19 epidemiology and surveillance team; de Melker HE, Geubbels E, van den Hof S, Wallinga J. de Boer PT, et al. Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug. Influenza Other Respir Viruses. 2023. PMID: 37621921 Free PMC article.
A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021.
Ainslie KEC, Backer JA, de Boer PT, van Hoek AJ, Klinkenberg D, Korthals Altes H, Leung KY, de Melker H, Miura F, Wallinga J. Ainslie KEC, et al. Among authors: de boer pt. Euro Surveill. 2022 Nov;27(44):2101090. doi: 10.2807/1560-7917.ES.2022.27.44.2101090. Euro Surveill. 2022. PMID: 36330824 Free PMC article.
Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands.
de Boer PT, de Lange MMA, Wielders CCH, Dijkstra F, van Roeden SE, Bleeker-Rovers CP, Oosterheert JJ, Schneeberger PM, van der Hoek W. de Boer PT, et al. Emerg Infect Dis. 2020 Feb;26(2):238-246. doi: 10.3201/eid2602.181772. Emerg Infect Dis. 2020. PMID: 31961297 Free PMC article.
Targeted Screening for Chronic Q Fever, the Netherlands.
Reukers DFM, de Boer PT, Loohuis AO, Wever PC, Bleeker-Rovers CP, van Gageldonk-Lafeber AB, van der Hoek W, Timen A. Reukers DFM, et al. Among authors: de boer pt. Emerg Infect Dis. 2022 Jul;28(7):1403-1409. doi: 10.3201/eid2807.212273. Emerg Infect Dis. 2022. PMID: 35731163 Free PMC article.
32 results